...
首页> 外文期刊>The Internet Journal of Nanotechnology >A Study Of Genetic Engineering Techniques In Biotechnology Based Pharmaceuticals
【24h】

A Study Of Genetic Engineering Techniques In Biotechnology Based Pharmaceuticals

机译:基于生物技术的药物中的基因工程技术研究

获取原文
           

摘要

Modern pharmaceutical biotechnology encompasses gene cloning and recombinant DNA technology. The prime focus of the study was to know in depth of the concepts of Genetic engineering that are implemented in pharmaceutical industry. This study unleashes the paramount significance of Genetic engineering emerged out with outstanding success. Pharmaceutical trends are moving towards two profound technologies the first being Novel Drug Delivery system.. This review work ensures the concepts of Recombinent DNA , and the hybridoma techniques that are implemented in drug discovery and research. Genetic engineering now allows biological synthesis and large-scale production of several proteins with therapeutic potential. The principal challenge in this sphere is to identify new, medically and commercially significant targets. In the future, genetic engineering will surely provide invaluable tools for the study of the molecular basis of cellular control and pathophysiology, which will permit biochemists and medicinal chemists to design novel medicines. Introduction Biotechnology is the application of scientific and engineering principles to the processing of materials by biological agents to provide goods and service. This review provides an in-depth look at the most promising major biologics (blood, blood components and derivatives, allergenic and vaccines) that include biotechnology based drugs and products (therapeutic proteins, recombinant DNA vaccines, gene therapies, and devices).During the early days of genetic engineering, the availability of this remarkable new technology produced a sense that the world of science was experiencing a momentous occasion. Because it is a technology that is evolving and finding new applications ,it is constantly providing new challenges and impressions.New biotechnology comprises genetic engineering, protoplast fusion and monoclonal (citation) antibody techniques, powerful new “tools” designed to generate efficient bioprocesses and products for the pharmaceutical industry. The following areas of biotechnology are highlighted: human insulin, interferons and other growth factors, neuroactive peptides, blood products, antibiotics, enzymes, monoclonal antibodies, vaccines and oncogenes. Biotechnology has helped the bio-industries in producing the novel compounds and optimization, and scale up products, including single protein and mycoprotein. The genetic engineering is not a single technique but represents a collection of interrelated techniques, including recombinant recombinent DNA technology, that together permits scientists to manipulate genetic information; to express this genetic information in a defined manner; and, as a result, to convert microorganisms into minifactories capable of manufacturing desired gene products. Principles of Tools of Genetic Engineering The fundamental unit of a genome that control heredity is known as gene. The recent work on structure of chromosomes and deoxyribonucleic acid clearly defines the gene as “a small segment of polynucleotide chain consisting of hundreds or thousands of nucleotide”.There are various biological tools which are used to carry out manipulation of genetic materials and cells as well, for example enzymes, foreign or passenger DNA, cDNA bank and gene bank.Exonucleases These enzymes act upon genome and digest the base pairs on 5’ or 3’ ends of a single nicks or gaps in double stranded DNA.EndonucleasesThey act upon genetic material and cleave the double stranded DNA at any pointy except the ends, but their action involves only one strand of the duplex.Restriction endonucleasesThese enzymes occur naturally in bacteria as a chemical weapon against invading viruses and cut both strands of DNA when certain foreign nucleotides are introduced in the cell. DNA LigasesMertz and Davis (1972) for the first time demonstrated that cohesive termini of cleaved DNA molecule could be covalently sealed with E.coli DNA ligase and were able to produce recombinant DNA
机译:现代药物生物技术包括基因克隆和重组DNA技术。该研究的主要重点是深入了解制药工业中实施的基因工程的概念。这项研究释放了基因工程的最重要意义,并取得了巨大的成功。制药趋势正在朝着两项深刻的技术发展:第一个是新型药物递送系统。这项审查工作可确保重组DNA的概念以及在药物发现和研究中实施的杂交瘤技术。基因工程现在允许生物合成和具有治疗潜力的几种蛋白质的大规模生产。这个领域的主要挑战是确定新的,具有医学和商业意义的目标。将来,基因工程必将为细胞控制和病理生理学的分子基础研究提供宝贵的工具,这将使生物化学家和药物化学家能够设计新药。简介生物技术是将科学和工程原理应用于由生物制剂提供材料和服务的材料加工过程中。这篇综述深入探讨了最有前途的主要生物制品(血液,血液成分和衍生物,过敏原和疫苗),包括基于生物技术的药物和产品(治疗性蛋白质,重组DNA疫苗,基因疗法和设备)。在基因工程的早期,这项非凡的新技术的出现使人感觉到科学界正处于一个重大时刻。因为它是一项不断发展的技术,并且正在寻找新的应用,所以它不断地带来新的挑战和印象。新的生物技术包括基因工程,原生质体融合和单克隆(引证)抗体技术,旨在产生有效的生物过程和产品的强大的新“工具”用于制药行业。重点介绍了生物技术的以下领域:人胰岛素,干扰素和其他生长因子,神经活性肽,血液制品,抗生素,酶,单克隆抗体,疫苗和致癌基因。生物技术已帮助生物工业生产新型化合物并进行了优化,并扩大了产品规模,包括单一蛋白和霉菌蛋白。基因工程不是一个单一的技术,而是代表了一系列相互关联的技术,包括重组重组DNA技术,这些技术共同使科学家能够操纵遗传信息。以明确的方式表达这种遗传信息;结果,将微生物转化为能够生产所需基因产物的微型工厂。基因工程工具的原理控制遗传的基因组的基本单位称为基因。最近关于染色体和脱氧核糖核酸结构的研究明确地将该基因定义为“由数百或数千个核苷酸组成的多核苷酸链的一小段”。还有各种生物学工具也可用于操纵遗传物质和细胞核酸外切酶这些酶作用于基因组并消化单切口5'或3'末端的碱基对或双链DNA的缺口。核酸内切酶作用于遗传物质。并在末端以外的任何尖端切割双链DNA,但它们的作用仅涉及双链体的一条链。限制性核酸内切酶这些细菌天然存在于细菌中,作为抵御病毒的化学武器,并在引入某些外来核苷酸时切断了DNA的两条链在牢房里。 DNA LigasesMertz和Davis(1972)首次证明,裂解的DNA分子的内聚末端可以用大肠杆菌DNA连接酶共价密封,并能够产生重组DNA

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号